Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer^{†‡§¶‖}

A cancer and leukemia group B study

1. Alice B. Kornblith PhD^1,††,*,
2. Jeannette M. Dowell MS²,
3. James E. Herndon II PhD²,
4. Beverly J. Engelman MS³,
5. Susan Bauer-Wu DNSc, RN¹,
6. Eric J. Small MD⁴,
7. Vicki A. Morrison MD⁵,
8. James Atkins MD⁶,
9. Harvey Jay Cohen MD⁷,
10. Jimmie C. Holland MD³

Article first published online: 31 OCT 2006

DOI: 10.1002/cncr.22296

Copyright © 2006 American Cancer Society

Issue

1. ^†

   This article is a US Government work and, as such, is in the public domain in the United States of America.

2. ^‡

   Published in abstract form in Kornblith AB, Dowell JM, Herndon II JE, et al. Telephone monitoring: early identification of psychological, physical and social distress in older advanced stage cancer patients. Psychooncology. 2006; 15:S21-S22. Abstract VIII.

3. ^§

   The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute.

4. ^¶

   The authors dedicate this article to the memory of Ms. Sylvia Rosenberg, who served as an extraordinary telephone monitor in the study.

5. ^‖

   The following institutions participated in this study, listed with their grant support: CALGB Statistical Center, Durham, NC (Stephen George, PhD; supported by National Cancer Institute [NCI] Grant CA33601); Christiana Care Health Services, Inc. Community Clinical Oncology Program (CCOP), Wilmington, DE (Stephen Grubbs, MD; supported by NCI Grant CA45418); Dana Farber Cancer Institute, Boston, MA (George P Canellos, MD; supported by NCI Grant CA32291); Dartmouth Medical School-Norris Cotton Cancer Center, Lebanon, NH (Marc S. Ernstoff, MD; supported by NCI Grant CA04326); Duke University Medical Center, Durham, NC (Jeffrey Crawford, MD; supported by NCI Grant CA47577); Memorial Sloan-Kettering Cancer Center, New York, NY (Clifford Hudis, MD; supported by NCI Grant CA77651); Missouri Baptist Medical Center, St. Louis, MO (Alan P. Lyss, MD); Ohio State University Medical Center, Columbus, OH (Clara D Bloomfield, MD; supported by NCI Grant CA77658); Roswell Park Cancer Institute, Buffalo, NY (Ellis Levine, MD; supported by NCI Grant CA02599); Southeast Cancer Control Consortium Inc. CCOP, Goldsboro, NC (James N. Atkins, MD; supported by NCI Grant CA45808); State University of New York-Upstate Medical University, Syracuse NY (Stephen L. Graziano, MD; supported by NCI Grant CA21060); University of California at San Diego, San Diego, CA (Stephen L. Seagren, MD; supported by NCI Grant CA11789; University of California at San Francisco, San Francisco, CA (Alan P. Venook, MD; supported by NCI Grant CA60138); University of Chicago Medical Center, Chicago, IL (Gini Fleming, MD; supported by NCI Grant CA41287); University of Illinois Minority-Based, CCOP, Chicago, IL (Lawrence E. Feldman, MD; supported by NCI Grant CA74811); University of Minnesota, Minneapolis, MN (Bruce A Peterson, MD; supported by NCI Grant CA16450); University of Missouri/Ellis Fischel Cancer Center, Columbia, MO (Michael C. Perry, MD; supported by NCI Grant CA12046); University of North Carolina at Chapel Hill, Chapel Hill, NC (Thomas C. Shea, MD; supported by NCI Grant CA47559); Vermont Cancer Center, Burlington, VT (Hyman B. Muss, MD; supported by NCI Grant CA77406); Wake Forest University School of Medicine, Winston-Salem, NC (David D Hurd, MD; supported by NCI Grant CA03927); Walter Reed Army Medical Center, Washington, DC (Thomas Reid, MD; supported by NCI Grant CA26806); Washington University School of Medicine, St. Louis, MO (Nancy Bartlett, MD; supported by NCI Grant CA77440); Weill Medical College of Cornell University, New York, NY (Scott Wadler, MD; supported by NCI Grant CA07968); and Western Pennsylvania Cancer Institute, Pittsburgh, PA (Richard K. Shadduck, MD).